(2024)
Risk assessment with gene expression markers in sepsis development.
Cell Rep Med 5(9),
101712.

Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Head +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Main Research Areas
- Microbiome in health and disease
- Systems biology of infections diseases
- Personalized nutrition
Publications
(2024)
In-vitro influence of specific Bacteroidales strains on gut and liver health related to Metabolic dysfunction-associated fatty liver disease.
Probiotics Antimicrob Proteins
[Epub ahead of print]
(2024)
Saccharomyces boulardii enhances anti-inflammatory effectors and AhR activation via metabolic interactions in probiotic communities.
ISME Journal 18(1),
wrae212.
(2024)
CD56-mediated activation of human natural killer cells is triggered by Aspergillus fumigatus galactosaminogalactan.
PLOS Pathog 20(6),
e1012315.
(2024)
Deep phenotyping of patients with MASLD upon high-intensity interval training.
JHEP Reports ,
(2024)
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota.
Nat Metab 6(3),
578-597.
(2024)
A global survey of host, aquatic, and soil microbiomes reveals shared abundance and genomic features between bacterial and fungal generalists.
Cell Rep 43(4),
114046.
(2024)
Life goes on: Spatial heterogeneity promotes biodiversity in an urbanized coastal marine ecosystem.
Glob Chang Biol 30(4),
e17248.
(2024)
Controlling substrate- and stereospecificity of condensation domains in nonribosomal peptide synthetases.
ACS Chem Bio 19(3),
599-606.
(2024)
Strain dynamics of contaminating bacteria modulate the yield of ethanol biorefineries.
Nat Commun 15(1),
5323.